These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965 [TBL] [Abstract][Full Text] [Related]
6. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor. Al-Hussaini M; Hirschowitz L; McCluggage WG Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652 [TBL] [Abstract][Full Text] [Related]
8. Primary Intracranial Atypical Teratoid/Rhabdoid Tumors: A Clinicopathologic and Neuroradiologic Study. Zhao RJ; Wu KY; Zhang JG; Ma YH; Kong LF J Child Neurol; 2015 Jul; 30(8):1017-23. PubMed ID: 25323739 [TBL] [Abstract][Full Text] [Related]
9. Ewing Sarcoma and Atypical Teratoid Rhabdoid Tumor: A FISH and Immunohistochemical Comparison. Pacheco MC; Dolan M; Bendel A Pediatr Dev Pathol; 2017; 20(5):381-386. PubMed ID: 28382842 [TBL] [Abstract][Full Text] [Related]
10. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928 [TBL] [Abstract][Full Text] [Related]
11. Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review. Wagner LM; Garrett JK; Ballard ET; Hill DA; Perry A; Biegel JA; Collins MH Pediatr Dev Pathol; 2007; 10(5):409-15. PubMed ID: 17929989 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [TBL] [Abstract][Full Text] [Related]
13. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression. Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579 [TBL] [Abstract][Full Text] [Related]
14. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [TBL] [Abstract][Full Text] [Related]
15. INI1 (BAF 47) immunohistochemistry is an essential diagnostic tool for children with hepatic tumors and low alpha fetoprotein. Al Nassan A; Sughayer M; Matalka I; Ghandour K; Masarweh M; Zimmermann A; Sultan I J Pediatr Hematol Oncol; 2010 Mar; 32(2):e79-81. PubMed ID: 20048688 [TBL] [Abstract][Full Text] [Related]
16. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370 [TBL] [Abstract][Full Text] [Related]
17. Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas. Kreiger PA; Judkins AR; Russo PA; Biegel JA; Lestini BJ; Assanasen C; Pawel BR Mod Pathol; 2009 Jan; 22(1):142-50. PubMed ID: 18997735 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre. Rekhi B; Jambhekar NA Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062 [TBL] [Abstract][Full Text] [Related]
19. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295 [TBL] [Abstract][Full Text] [Related]
20. [Pathologic diagnosis of malignant rhabdoid tumor of skin]. Huang H; Xu H; Zeng S; Yang W; Huang J; Wu Y; Xiong F; Zeng H Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):334-5. PubMed ID: 25030868 [No Abstract] [Full Text] [Related] [Next] [New Search]